Toggle Main Menu Toggle Search

Open Access padlockePrints

What do we know about survivorship after treatment for extremity sarcoma? A systematic review.

Lookup NU author(s): Sherron Furtado, Craig Gerrand

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

AbstractObjectiveThe varied presentations and treatments of extremity bone and soft tissue sarcoma mean that the issues faced by survivors are diverse and complex. The aim of this systematic review was to investigate what is known about this topic with a view to identifying areas for further research or service development.MethodsThis was a review of the English language literature identified from Medline and Ovid and hand searches published between January 2000 and September 2012. Results were compiled according to physical, psychological and social domains of survivorship.ResultsOf 182 studies identified, 22 met the inclusion criteria. There is a wide range of outcome measures used and a need for more objective measures. Unsurprisingly, survivors of extremity sarcoma typically demonstrate lower levels of physical functioning than healthy controls. In addition, survivors demonstrate a substantial psychological morbidity.ConclusionsServices for survivors of extremity sarcoma should include rehabilitation and psychological support, sexual health services, expert pain management, and support to return to work.


Publication metadata

Author(s): Ng Kee Kwong T, Furtado S, Gerrand C

Publication type: Article

Publication status: Published

Journal: European Journal of Surgical Oncology

Year: 2014

Volume: 40

Issue: 9

Pages: 1109–1124

Print publication date: 01/09/2014

Online publication date: 04/04/2014

Acceptance date: 19/03/2014

ISSN (print): 0748-7983

ISSN (electronic): 1532-2157

Publisher: Elsevier Ltd

URL: http://dx.doi.org/10.1016/j.ejso.2014.03.015

DOI: 10.1016/j.ejso.2014.03.015

PubMed id: PMID: 24767804


Altmetrics

Altmetrics provided by Altmetric


Share